{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "East Windsor",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA200268"
        ],
        "brand_name": [
          "PIOGLITAZONE"
        ],
        "generic_name": [
          "PIOGLITAZONE"
        ],
        "manufacturer_name": [
          "Rising Pharma Holdings, Inc."
        ],
        "product_ndc": [
          "57237-219",
          "57237-220",
          "57237-221"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "PIOGLITAZONE HYDROCHLORIDE"
        ],
        "rxcui": [
          "312440",
          "312441",
          "317573"
        ],
        "spl_id": [
          "f3308268-8023-434e-8caf-734ca298b98e"
        ],
        "spl_set_id": [
          "4483b1c6-7095-4a63-8128-ac2d91e11040"
        ],
        "package_ndc": [
          "57237-219-30",
          "57237-219-90",
          "57237-219-05",
          "57237-220-30",
          "57237-220-90",
          "57237-220-05",
          "57237-221-30",
          "57237-221-90",
          "57237-221-05"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0357237221303",
          "0357237220306",
          "0357237219300"
        ],
        "unii": [
          "JQT35NPK6C"
        ]
      },
      "product_type": "Drugs",
      "event_id": "89323",
      "recalling_firm": "Aurobindo Pharma USA Inc.",
      "address_1": "279 Princeton Hightstown Rd",
      "address_2": "",
      "postal_code": "08520-1401",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-0450-2022",
      "product_description": "Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05",
      "product_quantity": "792 bottles",
      "reason_for_recall": "Superpotent and Failed Tablet/Capsule Specifications",
      "recall_initiation_date": "20211229",
      "center_classification_date": "20220124",
      "termination_date": "20231204",
      "report_date": "20220202",
      "code_info": "Batch # PF4520028B & PF4520028A, Exp. Date 11/2022",
      "more_code_info": ""
    }
  ]
}